Tag Archives: Another

Post-June 21 social distancing plan won’t be revealed for another WEEK

Plans for social distancing and ‘Covid certificates’ after June 21 won’t be revealed for another WEEK despite rising hopes that ‘freedom day’ WILL go ahead Social distancing and Covid certificate reviews not expected until next week Boris Johnson had promised they would be revealed by the end of this month Hopes rising that the June… Read More »

Convalescent plasma: another controversial clash of politics & science

You’d need a pretty big, stiff broom to sweep away all of the hype dished out by the Trump Administration as it announced an Emergency Use Authorization for convalescent plasma – the liquid component of blood that may be tapped for disease-fighting antibodies from people who’ve been infected with COVID-19. Before the announcement was even… Read More »

Another conflicted all-expenses-paid junket offer by the National Press Foundation

Two months from now we will be in mid-winter, late January. How about four days in warm, sunny West Palm Beach, Florida? All-expenses-paid. How inviting. But how troubling.  Once again. An email was sent to journalists this week announcing this junket funded by Bayer, a multinational drug company.  Bayer markets a number of cardiovascular drugs… Read More »

Daily on Healthcare: The boozeless bunch: Will another teetotaler be sworn in as president?

WILL ANOTHER TEETOTALER BE SWORN IN AS PRESIDENT? Voters may not have the option of using the “who would you rather have a beer with?” test this election to decide among the presidential candidates. That’s because at least four people vying for the White House abstain from alcohol: President Trump, Democratic front runner Joe Biden,… Read More »

AstraZeneca rockets toward Tagrisso sales target with another survival win

AstraZeneca already has a Tagrisso approval for patients with previously untreated, EGFR-mutated lung cancer. But it’s shoring up its case with some clutch new data. Friday, the British drugmaker said Tagrisso had beaten out Roche’s rival drug Tarceva and AstraZeneca’s own Iressa at helping patients live longer. The showing came as part of the phase 3 Flaura… Read More »

Another big private insurer just vowed to fight ‘Medicare for All’ plans in Washington

Senator Bernie Sanders, an independent from Vermont, speaks during a health care bill news conference on Capitol Hill in Washington, D.C., U.S., on Wednesday, Sept. 13, 2017. Andrew Harrer | Bloomberg | Getty Images Humana CEO Bruce Broussard warned U.S. lawmakers Wednesday the insurer won’t back any legislation that makes private health coverage illegal as… Read More »